Agilon Health (AGL) Return on Equity (2020 - 2025)
Agilon Health's Return on Equity history spans 6 years, with the latest figure at 0.0% for Q2 2025.
- For Q2 2025, Return on Equity rose 10.0% year-over-year to 0.0%; the TTM value through Jun 2025 reached 0.0%, up 10.0%, while the annual FY2025 figure was 0.05%, 6.0% up from the prior year.
- Return on Equity reached 0.0% in Q2 2025 per AGL's latest filing, down from 0.0% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.02% in Q2 2021 to a low of 0.11% in Q1 2024.
- Average Return on Equity over 5 years is 0.03%, with a median of 0.01% recorded in 2023.
- Peak YoY movement for Return on Equity: dropped -12bps in 2024, then grew 11bps in 2025.
- A 5-year view of Return on Equity shows it stood at 0.02% in 2021, then soared by 100bps to 0.0% in 2022, then tumbled by -780721bps to 0.09% in 2023, then soared by 96bps to 0.0% in 2024, then grew by 20bps to 0.0% in 2025.
- Per Business Quant, the three most recent readings for AGL's Return on Equity are 0.0% (Q2 2025), 0.0% (Q1 2025), and 0.0% (Q4 2024).